Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Novartis bullish on Afinitor cancer drug despite new competition
Novartis bullish on Afinitor cancer drug despite new competition
Novartis bullish on Afinitor cancer drug despite new competition
Submitted by
admin
on July 21, 2015 - 6:52pm
Source:
Yahoo/Reuters
News Tags:
Novartis
Afinitor
Opdivo
Cometriq
Exelixis
Bristol-Myers Squibb
Headline:
Novartis bullish on Afinitor cancer drug despite new competition
Do Not Allow Advertisers to Use My Personal information
